Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction

Antioxidants and Redox Signaling

Volumn 15, Issue 4, 2011, Pages 933-948

  Fleissner, Felix ^a   Thum, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ALISKIREN; ARGININE; AVE 9488; CLOPIDOGREL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPLERENONE; ESTROGEN; GLITAZONE DERIVATIVE; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OLMESARTAN; ORGANIC NITRATE; PENTAERYTHRITYL TETRANITRATE; PIOGLITAZONE; RAMIPRIL; REACTIVE OXYGEN METABOLITE; RESVERATROL; SCATTER FACTOR; SECRETONEURIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AGING; CARDIOVASCULAR DISEASE; CELL AGING; CELL COUNT; CELL FUNCTION; CELL GROWTH; COLONY FORMING UNIT; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; EXERCISE; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STABLE ANGINA PECTORIS;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 79960392882     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3502     Document Type: Review

References (138)

1. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, Walsh K, and Sessa WC. Akt1=protein kinase B alpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 115: 2119-2127, 2005. (Pubitemid 41134153)
2. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, and Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003. (Pubitemid 37466185)
3. Amano K, Okigaki M, Adachi Y, Fujiyama S, Mori Y, Kosaki A, Iwasaka T, and Matsubara H. Mechanism for IL-1b-mediated neovascularization unmasked by IL-1b knockout mice. J Mol Cell Cardiol 36: 469-480, 2004. (Pubitemid 38469938)
4. Andreou I, Tousoulis D, Tentolouris C, Antoniades C, and Stefanadis C. Potential role of endothelial progenitor cells in the pathophysiology of heart failure: Clinical implications and perspectives. Atherosclerosis 189: 247-254, 2006. (Pubitemid 44634506)
5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999. (Pubitemid 29377293)
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-966, 1997.
7. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, and Fliser D. Stimulation of endothelial progenitor cells: A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45: 526-529, 2005. (Pubitemid 40411254)
8. Balestrieri ML, Schiano C, Felice F, Casamassimi A, Balestrieri A, Milone L, Servillo L, and Napoli C. Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J Biochem 143: 179-186, 2008. (Pubitemid 351249832)
9. Bauer M and Bauer I. Heme oxygenase-1: Redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal 4: 749-758, 2002. (Pubitemid 35246937)
10. Bauersachs J and Thum T. Endothelial progenitor cell dysfunction: Mechanisms and therapeutic approaches. Eur J Clin Invest 37: 603-606, 2007. (Pubitemid 47063098)
11. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, and Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713, 2009.
12. Breen DM, Chan KK, Dhaliwall JK, Ward MR, Al Koudsi N, Lam L, De Souza M, Ghanim H, Dandona P, Stewart DJ, Bendeck MP, and Giacca A. Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol 29: 1060-1066, 2009.
13. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MVG, Hoydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, and Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618, 2007. (Pubitemid 46828487)
14. Chen J, Li HW, Addabbo F, Zhang F, Pelger E, Patschan D, Park HC, Kuo MC, Ni J, Gobe G, Chander PN, Nasjletti A, and Goligorsky MS. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes. Am J Pathol 174: 701-711, 2009.
15. Chen JF, Song MB, Yu SY, Gao P, Yu Y, Wang H, and Huang L. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overexpression of cell oxidant stress. Mol Cell Biochem 335: 137-146, 2010.
16. Choi JH, Hur J, Yoon CH, Kim JH, Lee CS, Youn SW, Oh IY, Skurk C, Murohara T, Park YB, Walsh K, and Kim HS. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3 beta activity. J Biol Chem 279: 49430-49438, 2004. (Pubitemid 39625829)
17. Colleselli D, Bijuklic K, Mosheimer BA, and Kahler CM. Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 312: 2933-2941, 2006.
18. Dentelli P, Rosso A, Balsamo A, Colmenares Benedetto S, Zeoli A, Pegoraro M, Camussi G, Pegoraro L, and Brizzi MF. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 109: 4264-4271, 2007. (Pubitemid 46743392)
19. Devin JK, Vaughan DE, Blevins J, Chen Q, Covington J, Verity DK, and Young PP. Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults. Growth Hormone IGF Res 18: 253-263, 2008. (Pubitemid 351479931)
20. Di Stefano V, Cencioni C, Zaccagnini G, Magenta A, Capogrossi MC, and Martelli F. p66(ShcA) modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc Res 82: 421-429, 2009.
21. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, and Zeiher AM. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase=Akt pathway. J Clin Invest 108: 391-397, 2001. (Pubitemid 32730785)
22. Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, and Kearney MT. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: The early role of reactive oxygen species. Am J Physiol Endocrinol Metab 293: E1311-E1319, 2007. (Pubitemid 350106599)
23. Fiorito C, Balestrieri ML, Crimi E, Giovane A, Grimaldi V, Minucci PB, Servillo L, D'Armiento FP, Farzati B, and Napoli C. Effect of l-arginine on circulating endothelial progenitor cells and VEGF after moderate physical training in mice. Intl J Cardiol 126: 421-423, 2008.
24. Fleissner F and Thum T. The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function. Mol Med 14: 235-237, 2008. (Pubitemid 351785695)
25. Fleissner F, Jazbutyte V, Fiedler J, Gupta SK, Yin X, Xu Q, Galuppo P, Kneitz S, Mayr M, Ertl G, Bauersachs J, and Thum T. Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ Res 107: 138-143, 2010.
26. Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, Jones J, Goldschmidt-Clermont PJ, and Loscalzo J. Heterozygous cellular glutathione peroxidase deficiency in the mouse: Abnormalities in vascular and cardiac function and structure. Circulation 106: 1154-1158, 2002. (Pubitemid 34970859)
27. Forstermann U and Munzel T. Endothelial nitric oxide dynthase in vascular disease: From marvel to menace. Circulation 113: 1708-1714, 2006.
28. Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, and Bauersachs J. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation 118: 818-827, 2008.
29. Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, Ouchi N, Leopold JA, Loscalzo J, and Walsh K. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98: 254-261, 2006.
30. Gertz K, Priller J, Kronenberg G, Fink KB, Winter B, Schrock H, Ji S, Milosevic M, Harms C, Bohm M, Dirnagl U, Laufs U, and Endres M. Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res 99: 1132-1140, 2006. (Pubitemid 44729938)
31. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvath T, Jiang H, Sorrentino SA, Steenken N, Manes C, Marzilli M, Rudolph KL, Luscher TF, Drexler H, and Landmesser U. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: Relation to endothelial dysfunction. Hypertension 55: 1389-1397, 2010.
32. Goette A, Wolfram O, Jentsch-Ullrich K, Martens-Lobenhoffer J, Scalera F, Lendeckel U and Bode-Böger SM. The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA. Int J Cardiol 143: 264-270, 2010.
33. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, and Simari RD. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93: 1023-1025, 2003. (Pubitemid 37485031)
34. Haddad P, Dussault S, Groleau J, Turgeon J, Michaud SE, Menard C, Perez G, Maingrette F, and Rivard A. Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. Arterioscler Thromb Vasc Biol 29: 1522-1528, 2009.
35. Hamed S, Brenner B, Aharon A, Daoud D, and Roguin A. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol 8: 56, 2009.
36. He T, Joyner MJ, and Katusic ZS. Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells. Microvasc Res 78: 447-452, 2009.
37. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MAS, Werb Z, and Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 109: 625-637, 2002. (Pubitemid 34628725)
38. Hiasa Ki, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, Sata M, Ichiki T, Takeshita A, and Egashira K. Gene transfer of stromal cell-derived factor-1{alpha} enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor=endothelial nitric oxide synthaserelated pathway: Next generation chemokine therapy for therapeutic neovascularization. Circulation 109: 2454-2461, 2004. (Pubitemid 38679567)
39. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003. (Pubitemid 36204953)
40. Hirschi KK, Ingram DA, and Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1584-1595, 2008.
41. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY, Sata M, Chen JW, and Lin SJ. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30: 869-877, 2010.
42. Imanishi T, Hano T, and Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 23: 97-104, 2005. (Pubitemid 40128986)
43. Imanishi T, Hano T, Sawamura T, and Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31: 407-413, 2004. (Pubitemid 39044118)
44. Imanishi T, Kobayashi K, Kuroi A, Ikejima H, and Akasaka T. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell. Hypertens Res 31: 757-765, 2008. (Pubitemid 351772867)
45. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, and Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760, 2004. (Pubitemid 39434958)
46. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, and Losordo DW. Estrogen-mediated, endothelial nitric oxide synthasedependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121, 2003. (Pubitemid 38031801)
47. Javanmard SH, Gheisari Y, Soleimani M, Nematbakhsh M, and Monajemi A. Effect of L-arginine on circulating endothelial progenitor cells in hypercholesterolemic rabbits. Int J Cardiol 143: 213-216, 2010.
48. Jenkins NT, Witkowski S, Spangenburg EE, and Hagberg JM. Effects of acute and chronic endurance exercise on intracellular nitric oxide in putative endothelial progenitor cells: Role of NAPDH oxidase. Am J Physiol Heart Circ Physiol 297: H1798-H1805, 2009.
49. Jiang M, Wang BY, Wang CQ, He B, Fan HH, Guo TB, Shao Q, Gao L, and Liu Y. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. J Cell Biochem 103: 321-334, 2008.
50. Khakoo AY and Finkel T. Endothelial progenitor cells. Annu Rev Med 56: 79-101, 2005. (Pubitemid 40299775)
51. Kielczewski JL, Jarajapu YPR, McFarland EL, Cai J, Afzal A, Li Calzi S, Chang KH, Lydic T, Shaw LC, Busik J, Hughes J, Cardounel AJ, Wilson K, Lyons TJ, Boulton ME, Mames RN, Chan-Ling T, and Grant MB. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 105: 897-905, 2009.
52. Kim SY, Park SY, Kim J, Kim JW, Kim M, Yang J, Kim J, Choi KH, Kim S, and Ryu HM. Differentiation of endothelial cells from human umbilical cord blood AC133 (-)CD14(\+) cells. Ann Hematol 84: 417-422, 2005. (Pubitemid 40867916)
53. Kobayashi N, Fukushima H, Takeshima H, Koguchi W, Mamada Y, Hirata H, Machida Y, Suzuki N, Yokotsuka F, Tabei K, Kobayashi E, Fukuda N, and Ishimitsu T. Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb. Am J Hypertens 23: 1007-1013, 2010.
54. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC, Pratt RE, and Dzau VJ. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109: 1769-1775, 2004. (Pubitemid 38500680)
55. Ladage D, Schü tzeberg N, Dartsch T, Krausgrill B, Halbach M, Zobel C, and Mü ller-Ehmsen J. Hyperaldosteronism is associated with a decrease in number and altered growth factor expression of endothelial progenitor cells in rats. Int J Cardiol 2010 Jan 28 [Epub ahead of print].
56. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, and Drexler H. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110: 1933-1939, 2004. (Pubitemid 39331904)
57. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, and Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220-226, 2004. (Pubitemid 38114143)
58. Liang C, Ren YS, Tan HB, He ZQ, Jiang QJ, Wu JX, Zhen Y, Fan M, and Wu ZG. Rosiglitazone via upregulation of Akt=eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br J Pharmacol 158: 1865-1873, 2009.
59. Lin HH, Chen YH, Yet SF, and Chau LY. After vascular injury, heme oxygenase-1=carbon monoxide enhances reendothelialization via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemostasis 7: 1401-1408, 2009.
60. Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, and van Zonneveld AJ. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199, 2004. (Pubitemid 38044715)
61. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, and Han ZC. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 47: 1227-1237, 2006. (Pubitemid 43830715)
62. McClung JA, Kruger AL, Ferraris A, Vanella L, Tsenovoy P, Weiss MB, and Abraham NG. Usefulness of clopidogrel to protect against diabetes-induced vascular damage. Am J Cardiol 105: 1014-1018, 2010.
63. Min TQ, Zhu CJ, Xiang WX, Hui ZJ, and Peng SY. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 18: 203-209, 2004. (Pubitemid 38918955)
64. Munzel T, Heitzer T, and Harrison DG. The physiology and pathophysiology of the nitric oxide superoxide system. Herz 22: 158-172, 1997. (Pubitemid 27282855)
65. Pandolfi A, Cetrullo D, Polishuck R, Alberta MM, Calafiore A, Pellegrini G, Vitacolonna E, Capani F, and Consoli A. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 21: 1378-1382, 2001. (Pubitemid 34219848)
66. Patschan D, Patschan S, Henze E, Wessels JT, Koziolek M, and Muller GA. LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence. J Clin Apheresis 24: 180-185, 2009.
67. Perry TE, Song MJ, Despres DJ, Kim SM, San H, Yu ZX, Raghavachari N, Schnermann J, Cannon RO, and Orlic D. Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc Res 84: 317-325, 2009.
68. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, Zeiher AM, and Dimmeler S. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21: 2644-2658, 2007. (Pubitemid 47607673)
69. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, Boulanger CM, Westwood N, Urbich C, Willeit J, Steiner M, Breuss J, Xu Q, Kiechl S, and Mayr M. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114: 723-732, 2009.
70. Ramprasath VR and Jones PJH. Anti-atherogenic effects of resveratrol. Eur J Clin Nutr 64: 660-668, 2010.
71. Rehman J, Li J, Orschell CM, and March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte=macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003. (Pubitemid 36297209)
72. Sambuceti G, Morbelli S, Vanella L, Kusmic C, Marini C, Massollo M, Augeri C, Corselli M, Ghersi C, Chiavarina B, Rodella LF, L'Abbate A, Drummond G, Abraham NG, and Frassoni F. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 27: 399-407, 2009.
73. Sanada F, Taniyama Y, Azuma J, Iekushi K, Dosaka N, Yokoi T, Koibuchi N, Kusunoki H, Aizawa Y, and Morishita R. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 53: 77-82, 2009.
74. Sasaki K, Heeschen C, Aicher A, Ziebart T, Honold J, Urbich C, Rossig L, Koehl U, Koyanagi M, Mohamed A, Brandes RP, Martin H, Zeiher AM, and Dimmeler S. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 103: 14537-14541, 2006. (Pubitemid 44484785)
75. Schgoer W, Theurl M, Jeschke J, Beer AGE, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M, Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A, Bahlmann FH, Fischer-Colbrie R, Wolf D, and Kirchmair R. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism. Circ Res 105: 994-1002, 2009.
76. Schmidt D, Mol A, Neuenschwander S, Breymann C, Gossi M, Zund G, Turina M, and Hoerstrup SP. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 27: 795-800, 2005. (Pubitemid 40590049)
77. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, and Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987, 2005. (Pubitemid 40814192)
78. Schmieder RE, Hilgers KF, Schlaich MP, and Schmidt BM. Renin-angiotensin system and cardiovascular risk. The Lancet 369: 1208-1219, 2007. (Pubitemid 46527856)
79. Schuhmacher S, Schulz E, Oelze M, Konig A, Roegler C, Lange K, Sydow L, Kawamoto T, Wenzel P, Munzel T, Lehmann J, and Daiber A. A new class of organic nitrates: Investigations on bioactivation, tolerance and crosstolerance phenomena. Br J Pharmacol 158: 510-520, 2009.
80. Schulz E, Jansen T, Wenzel P, Daiber A, and Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115-1126, 2008. (Pubitemid 351451710)
81. Schwartz SM and Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 73: 651-653, 1976.
82. Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A, Beem E, Shaw LC, Li Calzi S, Harrison JK, Tran-Son-Tay R, and Grant MB. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55: 102-109, 2006. (Pubitemid 43343304)
83. Shen C, Li Q, Zhang YC, Ma G, Feng Y, Zhu Q, Dai Q, Chen Z, Yao Y, Chen L, Jiang Y, and Liu N. Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways. Biomed Pharmacother 64: 35-43, 2010.
84. Sone M, Itoh H, Yamashita J, Yurugi-Kobayashi T, Suzuki Y, Kondo Y, Nonoguchi A, Sawada N, Yamahara K, Miyashita K, Park K, Shibuya M, Nito S, Nishikawa SI, and Nakao K. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 107: 2085-2088, 2003. (Pubitemid 36532188)
85. Song MB, Yu XJ, Zhu GX, Chen JF, Zhao G, and Huang L. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Vasc Pharmacol 51: 205-213, 2008.
86. Sorrentino SA, Bahlmann FH, and Besler C. Oxidant stress impairs in vivo reendotheliazation capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus. Restoration by the peroxisome proliferator-activated receptor-[ gamma] agonist rosiglitazone. Circulation 116: 163-173, 2007. (Pubitemid 47057522)
87. Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, Mueller M, Horvath T, Doerries C, Heinemann M, Flemmer S, Markowski A, Manes C, Bahr MJ, Haller H, von Eckardstein A, Drexler H, and Landmesser U. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 121: 110-122, 2010.
88. Sorrentino SA, Bahlmann FH, Besler C, Muller M, Schulz S, Kirchhoff N, Doerries C, Horvath T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, and Landmesser U. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: Restoration by the peroxisome proliferator-activated receptor-{gamma} agonist rosiglitazone. Circulation 116: 163-173, 2007. (Pubitemid 47057522)
89. Steinmetz M, Nickenig G, and Werner N. Perspectives of regenerative mechanisms in cardiovascular disease spotlighting endothelial progenitor cells. Med Klin 104: 287-295, 2009.
90. Steinmetz M, Nickenig G, and Werner N. Endothelial-regenerating cells: An expanding universe. Hypertension 55: 593-599, 2010.
91. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Bohm M, and Nickenig G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107: 3059-3065, 2003. (Pubitemid 36758980)
92. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T. Ischemiaand cytokine-induced mobilization of bone marrowderived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999. (Pubitemid 29180584)
93. Tanabe T, Maeda S, Miyauchi T, Iemitsu M, Takanashi M, Irukayama-Tomobe Y, Yokota T,Ohmori H, andMatsuda M. Exercise training improves ageing-induced decrease in eNOS expression of the aorta. Acta Physiol Scand 178: 3-10, 2003. (Pubitemid 36577911)
94. Tang D, Lu J, Walterscheid JP, Chen HH, Engler DA, Sawamura T, Chang PY, Safi HJ, Yang CY, and Chen CH. Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. J Lipid Res 49: 33-47, 2008.
95. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, and Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002. (Pubitemid 35396976)
96. Thum T, Schmitter K, Fleissner F, Wiebking V, Dietrich, B. Widder, J. D., Jazbutyte V, Hahner S, Ertl G, and Bauersachs J. Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. Eur Heart J 2010 Oct 5 [Epub ahead of print].
97. Thum T, Wiebking V, Ertl G, and Bauersachs J. Organic nitrates differentially modulate circulating endothelial progenitor cells and endothelial function in patients with symptomatic coronary artery disease. Antioxid Redox Signal 15: 925-931, 2011.
98. Thum T and Bauersachs J. ADMA, endothelial progenitor cells, and cardiovascular risk. Circ Res 97: e84, 2005.
99. Thum T and Bauersachs J. Endothelial progenitor cells as potential drug targets. Curr Drug Targets Cardiovasc Haematol Disord 5: 277-286, 2005. (Pubitemid 41131699)
100. Thum T and Bauersachs J. Spotlight on endothelial progenitor cell inhibitors: Short review. Vasc Med 10 Suppl 1: S59-S64, 2005. (Pubitemid 43137269)
101. Thum T and Borlak J. LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents ac-tivation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. J Biol Chem 283: 19456-19464, 2008.
102. Thum T and Borlak J. Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoproteininduced vascular injury: Therapy through LOX-1 receptor antagonism? Circ Res 94: e1-13, 2004.
103. Thum T, Fleissner F, Klink I, Tsilkas D, Ertl G, Stichtenoth DO, and Bauersachs J. Growth hormone treatment of healthy middle-aged volunteers improves nitric oxide bioavailability and circulating endothelial progenitor cell levels via insulin-like growth factor-1. Circulation 116: 30, 2007.
104. Thum T, Fraccarollo D, Galuppo P, Tsikas D, Frantz S, Ertl G, and Bauersachs J. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc Res 70: 50-60, 2006.
105. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, and Bauersachs J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56: 666-674, 2007. (Pubitemid 46348461)
106. Thum T, Fraccarollo D, and Thum S. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. Arterioslcer Thromb Vasc Biol 27: 748-754, 2007. (Pubitemid 46606702)
107. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, and Bauersachs J. Age-dependent impairment of endothelial progenitor cells is corrected by growthhormone-mediated increase of insulin-like growth-factor-1. Circ Res 100: 434-443, 2007.
108. Thum T, Tsikas D, Frolich JC, and Borlak J. Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett 555: 567-571, 2003. (Pubitemid 37532612)
109. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, and Bauersachs J. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46: 1693-1701, 2005. (Pubitemid 41531624)
110. Thum T and Bauersachs J. MicroRNAs in cardiac hypertrophy and failure. Drug Discovery Today: Dis Mech 5: e279-e283, 2008.
111. Thum T and Bauersachs J. Spotlight on endothelial progenitor cell inhibitors: Short review. Vasc Med 10: S59-S64, 2005. (Pubitemid 43137269)
112. Thum T, Fleissner F, Klink I, Tsikas D, Jakob M, Bauersachs J, and Stichtenoth DO. Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-1. J Clin Endocrinol Metab: 92: 4172-4179, 2007. (Pubitemid 350074728)
113. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, and Bauersachs J. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 116: 258-267, 2007. (Pubitemid 47196561)
114. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JTR, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, and Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984, 2008.
115. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, and Ichijo H. ASK1 is required for sustained activations of JNK=p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228, 2001. (Pubitemid 32273301)
116. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, and Yodoi J. Redox control of cell death. Antioxid Redox Signal 4: 405-414, 2002. (Pubitemid 34753380)
117. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, and Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742, 2005. (Pubitemid 41464410)
118. Urbich C, Knau A, Fichtlscherer S, Walter DH, Bruhl T, Potente M, Hofmann WK, de Vos S, Zeiher AM, and Dimmeler S. FOXO-dependent expression of the proapoptotic protein Bim: Pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 19: 974-976, 2005. (Pubitemid 40827722)
119. van Zonneveld AJ, de Boer HC, van der Veer EP, and Rabelink TJ. Inflammation, vascular injury and repair in rheumatoid arthritis. Ann Rheum Dis 69: 57-60, 2010.
120. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM and Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001. (Pubitemid 32578123)
121. Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, Chin BY, Tzeng E, Ahmad S, Ahmed A, Baty CJ, and Otterbein LE. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121: 537-548, 2010.
122. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Pö ss J, Bauersachs J, Thum T, Pfreundschuh M, Mü ller P, Haendeler J, Böhm M, and Laufs U. Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. J Am Coll Cardiol 52: 470-482, 2008.
123. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, and Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24, 2003.
124. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, and Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005. (Pubitemid 41262334)
125. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, and Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol 22: 1567-1572, 2002.
126. Westerweel PE and Verhaar MC. Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol 5: 332-340, 2009.
127. Wilson AM, Harada R, Nair N, Balasubramanian N, and Cooke JP. L-Arginine supplementation in peripheral arterial disease: No benefit and possible harm. Circulation 116: 188-195, 2007. (Pubitemid 47057525)
128. Witkowski S, Lockard MM, Jenkins NT, Obisesan TO, Spangenburg EE, and Hagberg JM. Relationship between circulating progenitor cells, vascular function and oxidative stress with long-term training and short-term detraining in older men. Clin Sci 118: 303-311, 2010.
129. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, Gamble JR, and Stocker R. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29: 1537-1542, 2009.
130. Wu H, Riha GM, Yang H, Li M, Yao Q, and Chen C. Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells1,2. J Surg Res 126: 193-198, 2005. (Pubitemid 40779360)
131. Xia L, Wang XX, Hu XS, Guo XG, Shang YP, Chen HJ, Zeng CL, Zhang FR, and Chen JZ. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol 155: 387-394, 2008.
132. Xiao Q, Zeng L, Zhang Z, Margariti A, Ali ZA, Channon KM, Xu Q, and Hu Y. Sca-1\+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol 26: 2244-2251, 2006. (Pubitemid 44465718)
133. Yang YM, Huang A, Kaley G, and Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 297: H1829-H1836, 2009.
134. Yiu KH, Wang S, Mok MY, Ooi GC, Khong PL, Lau CP, Lai WH, Wong LY, Lam KF, Lau CS, and Tse HF. Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification. J Rheumatol 37: 529-535, 2010.
135. Zhao Q, Liu Z, Wang Z, Yang C, Liu J, and Lu J. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Ann Thor Surg 84: 544-552, 2007. (Pubitemid 47069188)
136. Zhao T, Li J, and Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 299: E110-116, 2010.
137. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, and Stewart DJ. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96: 442-450, 2005. (Pubitemid 40354538)
138. Zhou Z, Peng J, Wang CJ, Li D, Li TT, Hu CP, Chen XP, and Li YJ. Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens 28: 931-939, 2010.